Compare IPCA Labs with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS TORRENT PHARMA IPCA LABS/
TORRENT PHARMA
 
P/E (TTM) x 25.0 62.8 39.8% View Chart
P/BV x 4.8 8.4 57.9% View Chart
Dividend Yield % 0.4 1.2 36.8%  

Financials

 IPCA LABS   TORRENT PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-21
TORRENT PHARMA
Mar-21
IPCA LABS/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs2,4563,040 80.8%   
Low Rs1,3711,933 70.9%   
Sales per share (Unadj.) Rs423.3473.0 89.5%  
Earnings per share (Unadj.) Rs90.674.0 122.4%  
Cash flow per share (Unadj.) Rs107.1112.9 94.9%  
Dividends per share (Unadj.) Rs4.0035.00 11.4%  
Avg Dividend yield %0.21.4 14.9%  
Book value per share (Unadj.) Rs370.6344.9 107.5%  
Shares outstanding (eoy) m126.85169.22 75.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.55.3 86.0%   
Avg P/E ratio x21.133.6 62.9%  
P/CF ratio (eoy) x17.922.0 81.1%  
Price / Book Value ratio x5.27.2 71.6%  
Dividend payout %4.447.3 9.3%   
Avg Mkt Cap Rs m242,728420,798 57.7%   
No. of employees `000NANA-   
Total wages/salary Rs m10,13614,396 70.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,69980,048 67.1%  
Other income Rs m1,292757 170.6%   
Total revenues Rs m54,99180,806 68.1%   
Gross profit Rs m14,81224,666 60.1%  
Depreciation Rs m2,0926,578 31.8%   
Interest Rs m1233,583 3.4%   
Profit before tax Rs m13,89015,263 91.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,4012,744 87.5%   
Profit after tax Rs m11,48812,519 91.8%  
Gross profit margin %27.630.8 89.5%  
Effective tax rate %17.318.0 96.2%   
Net profit margin %21.415.6 136.8%  
BALANCE SHEET DATA
Current assets Rs m34,37055,232 62.2%   
Current liabilities Rs m11,33148,916 23.2%   
Net working cap to sales %42.97.9 543.7%  
Current ratio x3.01.1 268.6%  
Inventory Days Days4914 339.1%  
Debtors Days Days67 79.4%  
Net fixed assets Rs m26,29581,298 32.3%   
Share capital Rs m254846 30.0%   
"Free" reserves Rs m46,76357,526 81.3%   
Net worth Rs m47,01758,372 80.5%   
Long term debt Rs m36529,633 1.2%   
Total assets Rs m60,664136,530 44.4%  
Interest coverage x114.25.3 2,171.1%   
Debt to equity ratio x00.5 1.5%  
Sales to assets ratio x0.90.6 151.0%   
Return on assets %19.111.8 162.3%  
Return on equity %24.421.4 113.9%  
Return on capital %29.621.4 138.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27,17221,539 126.1%   
Fx outflow Rs m7,9497,136 111.4%   
Net fx Rs m19,22314,403 133.5%   
CASH FLOW
From Operations Rs m10,90120,107 54.2%  
From Investments Rs m-5,207-4,494 115.9%  
From Financial Activity Rs m-3,058-16,561 18.5%  
Net Cashflow Rs m2,636-893 -295.3%  

Share Holding

Indian Promoters % 46.3 71.3 65.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.0 20.6 213.2%  
FIIs % 11.0 10.9 101.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 28.8 186.8%  
Shareholders   115,335 63,229 182.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    

Yellow Ad

Advertisement

How to Find One Stock with Crorepati Potential?

There are three critical characteristics that differentiate a common stock from a potential 'crorepati' stock.

And we are going to reveal them during our 'One Stock Crorepati' MEGA summit on 30th June.

If you are interested in finding a potential 'crorepati' stock, don't miss this.

At this MEGA Summit we will reveal details of what we call a 'crorepati' stock...

You just cannot afford to miss this summit for anything.

Learn more



Today's Market

SGX Nifty Down 158 Points, Tata Motors' Price Hike, Ruchi Soya Becomes Patanjali Foods, and Top Buzzing Stocks Today(Pre-Open)

On Tuesday, Indian share markets witnessed a volatile trading session as crude oil prices rebounded following last week's rout.

Related Views on News

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jun 29, 2022 09:13 AM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS - AAYUSH FOOD & HERBS COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS